Key points are not available for this paper at this time.
EO IBD is rising, warranting physicians' alertness for IBD in elderly patients. The long-term outcome was not different from AO disease, despite a less frequent use of immunomodulators and biologicals.
Building similarity graph...
Analyzing shared references across papers
Loading...
Steven Jeuring
Tim van den Heuvel
Maurice P. Zeegers
Inflammatory Bowel Diseases
Maastricht University
Maastricht University Medical Centre
Zuyderland Medisch Centrum
Building similarity graph...
Analyzing shared references across papers
Loading...
Jeuring et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69df6e40d5404a0bea593177 — DOI: https://doi.org/10.1097/mib.0000000000000738